1
|
Cukierman DS, Paredes-Flores M, Guerra-Londono JJ, Carlson R, Hagan K, Ghebremichael S, Hagberg C, Ge PS, Raju GS, Rhim A, Cata JP. Corrigendum to "Nasal continuous positive pressure versus simple face mask oxygenation for adult obese and obstructive sleep apnea patients undergoing colonoscopy under propofol-based general anesthesia without tracheal intubation: A randomized controlled trial" [Journal of Clinical Anesthesia Volume 89 (2023)]. J Clin Anesth 2023:111346. [PMID: 37989650 DOI: 10.1016/j.jclinane.2023.111346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2023]
Affiliation(s)
- Daniel S Cukierman
- Department of Anesthesiology, Hospital Bernardino Rivadavia, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Manuel Paredes-Flores
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Juan J Guerra-Londono
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Richard Carlson
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Katherine Hagan
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Semhar Ghebremichael
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Carin Hagberg
- Department of Anesthesiology, Hospital Bernardino Rivadavia, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Phillip S Ge
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Gottumukkala S Raju
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Andrew Rhim
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Juan P Cata
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.
| |
Collapse
|
2
|
Avenatti E, Carrasco-Avila JA, Heidari B, Hagan K, Taha M, Nasir K. The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations. Curr Atheroscler Rep 2023; 25:889-898. [PMID: 37882944 DOI: 10.1007/s11883-023-01159-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/02/2023] [Indexed: 10/27/2023]
Abstract
PURPOSE OF REVIEW Stroke is the second leading cause of death and disability-adjusted life years worldwide, and the global lifetime risk of stroke is rising. Moreover, patients with a prior stroke are at high risk of recurrent events. We aimed at reviewing the evidence supporting aggressive secondary prevention strategies for lipid-lowering treatment in this population. RECENT FINDINGS Statins are the key players in such aggressive management; however, stroke survivors remain at significant residual risk suggesting the need for both better implementation of statin use as well as additional lipid lowering therapies. Newer drugs have become available and represent important tools in the management of patients with prior ischemic stroke. The role of lipid lowering treatment in hemorrhagic stroke is more controversial, given epidemiological data linking low lipid levels with increased risk of first and recurrent events. Aggressive secondary prevention strategies, including lipid lowering treatments, have proven to mitigate the risk of recurrent events in post-stroke patients. The tools available for treating such high-risk population have expanded beyond statins, and clinicians should familiarize themselves with them.
Collapse
Affiliation(s)
- E Avenatti
- Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA
| | | | - B Heidari
- Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA
| | - K Hagan
- Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA
- Center for Outcome Research Houston Methodist Hospital, Houston, TX, USA
| | - M Taha
- Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA
| | - K Nasir
- Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA.
- Center for Outcome Research Houston Methodist Hospital, Houston, TX, USA.
| |
Collapse
|
3
|
Roubaud MS, Hassan AM, Shin A, Mericli AF, Adelman DM, Hagan K, Popat K, Lin P, Moon B, Lewis VO. Outcomes of Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interfaces for Chronic Pain Control in the Oncologic Amputee Population. J Am Coll Surg 2023; 237:644-654. [PMID: 37278406 DOI: 10.1097/xcs.0000000000000778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
BACKGROUND Outcomes of targeted muscle reinnervation (TMR) and regenerative peripheral nerve interface (RPNI) in the oncologic population are limited. We sought to examine the safety and effectiveness of TMR and RPNI in controlling postamputation pain in the oncologic population. STUDY DESIGN A retrospective cohort study of consecutive patients who underwent oncologic amputation followed by immediate TMR or RPNI was conducted from November 2018 to May 2022. The primary study outcome was postamputation pain, assessed using the Numeric Pain Scale and Patient-Reported Outcomes Measurement Information System (PROMIS) for residual limb pain (RLP) and phantom limb pain (PLP). Secondary outcomes included postoperative complications, tumor recurrence, and opioid use. RESULTS Sixty-three patients were evaluated for a mean follow-up period of 11.3 months. The majority of patients (65.1%) had a history of previous limb salvage. At final follow-up, patients had an average Numeric Pain Scale score for RLP of 1.3 ± 2.2 and for PLP, 1.9 ± 2.6. The final average raw PROMIS measures were pain intensity 6.2 ± 2.9 (T-score 43.5), pain interference 14.6 ± 8.3 (T-score 55.0), and pain behavior 39.0 ± 22.1 (T-score 53.4). Patient opioid use decreased from 85.7% preoperatively to 37.7% postoperatively and morphine milligram equivalents decreased from a mean of 52.4 ± 53.0 preoperatively to 20.2 ± 38.4 postoperatively. CONCLUSIONS In the oncologic population TMR and RPNI are safe surgical techniques associated with significant reductions in RLP, PLP, and improvements in patient-reported outcomes. This study provides evidence for the routine incorporation of TMR and RPNI in the multidisciplinary care of oncologic amputees.
Collapse
Affiliation(s)
- Margaret S Roubaud
- From the Departments of Plastic and Reconstructive Surgery (Roubaud, Hassan, Mericli, Adelman), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Abbas M Hassan
- From the Departments of Plastic and Reconstructive Surgery (Roubaud, Hassan, Mericli, Adelman), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Ashley Shin
- University of Texas, McGovern Medical School, Houston, TX (Shin)
| | - Alexander F Mericli
- From the Departments of Plastic and Reconstructive Surgery (Roubaud, Hassan, Mericli, Adelman), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - David M Adelman
- From the Departments of Plastic and Reconstructive Surgery (Roubaud, Hassan, Mericli, Adelman), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Katherine Hagan
- Anesthesiology and Perioperative Medicine (Hagan, Popat), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Keyuri Popat
- Anesthesiology and Perioperative Medicine (Hagan, Popat), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Patrick Lin
- Orthopedic Surgery (Lin, Moon, Lewis), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Bryan Moon
- Orthopedic Surgery (Lin, Moon, Lewis), The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Valerae O Lewis
- Orthopedic Surgery (Lin, Moon, Lewis), The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
4
|
Cukierman DS, Perez M, Guerra-Londono JJ, Carlson R, Hagan K, Ghebremichael S, Hagberg C, Ge PS, Raju GS, Rhim A, Cata JP. Nasal continuous positive pressure versus simple face mask oxygenation for adult obese and obstructive sleep apnea patients undergoing colonoscopy under propofol-based general anesthesia without tracheal intubation: A randomized controlled trial. J Clin Anesth 2023; 89:111196. [PMID: 37406462 DOI: 10.1016/j.jclinane.2023.111196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2023] [Revised: 06/21/2023] [Accepted: 06/27/2023] [Indexed: 07/07/2023]
Abstract
STUDY OBJECTIVE To determine if a nasal positive airway pressure (nasal CPAP) mask would decrease the number of hypoxemic events in obese and obstructive sleep apnea patients undergoing colonoscopy. DESIGN Single-center prospective randomized controlled trial. SETTING Tertiary academic center. PATIENTS We enrolled 109 patients with diagnosis of obesity and/or obstructive sleep apnea scheduled to undergo colonoscopy under propofol general anesthesia without planned tracheal intubation. INTERVENTION Patients were randomly allocated (1:1 ratio) to receive supplementary oxygen at a flow of 10 L/min, either through a nasal CPAP or a simple facemask. MEASUREMENTS The primary endpoint was the difference in the mean percentage of time spent with oxygen saturation below 90% between the two groups. Secondary outcomes included the need for airway maneuvers/interventions, average SpO2 during the case, duration and severity of oxygen desaturation, incidence and duration of procedural interruptions, and satisfaction and tolerance scores. MAIN RESULTS 54 were allocated to the simple face mask and 55 to the nasal CPAP mask arms, respectively. A total of 6 patients experienced a hypoxemic event. Among these patients, the difference in the percentage of time spent with oxygen saturation below 90% was not clinically relevant (p = 1.0). However, patients in the nasal CPAP group required less chin lift (20% vs. 42.6%; p = 0.01) and oral cannula insertion (12.7% vs.29.6%; p = 0.03). The percentage of patients with at least one airway maneuver was higher in the simple face mask arm (68.5% vs. 41.8%; p = 0.005). Patient tolerance to device score was lower in the nasal CPAP group (8.85 vs. 9.56; p = 0.003). CONCLUSIONS A nasal CPAP did not prevent hypoxemia and should not be used routinely for colonoscopy in obese or OSA patients if a simple face mask is an alternative therapy. However, potential advantages of its use include fewer airway maneuvers or interventions, which may be desirable in certain clinical settings. TRIAL REGISTRATION Clinicaltrials.gov, identifier: NCT05175573.
Collapse
Affiliation(s)
- Daniel S Cukierman
- Department of Anesthesiology, Hospital Bernardino Rivadavia, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Manuel Perez
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Juan J Guerra-Londono
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Richard Carlson
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Katherine Hagan
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Semhar Ghebremichael
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Carin Hagberg
- Department of Anesthesiology, Hospital Bernardino Rivadavia, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Phillip S Ge
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Gottumukkala S Raju
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Andrew Rhim
- Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA
| | - Juan P Cata
- Department of Anesthesiology and Perioperative Medicine, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas - MD Anderson Cancer Center, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.
| |
Collapse
|
5
|
Paredes-Flores MA, Lasala JD, Moon T, Bhavsar S, Hagan K, Huepenbecker S, Carram NP, Ramirez MF, Maheswari K, Feng L, Cata JP. Incidence of acute kidney injury after noncardiac surgery in patients receiving intraoperative dexmedetomidine: a retrospective study. BJA Open 2023; 6:100136. [PMID: 37588172 PMCID: PMC10430864 DOI: 10.1016/j.bjao.2023.100136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Revised: 03/07/2023] [Accepted: 03/17/2023] [Indexed: 08/18/2023]
Abstract
Background Postoperative acute kidney injury (AKI) is a common complication and is associated with increased hospital length of stay and 30 day all-cause mortality. Unfortunately, we have neither a defined strategy to prevent AKI nor an effective treatment. In vitro, animal, and human studies have suggested that dexmedetomidine may have a renoprotective effect. We conducted a retrospective cohort study to evaluate if intraoperative dexmedetomidine was associated with a reduced incidence of AKI. Methods We collected data from 6625 patients who underwent major non-cardiothoracic cancer surgery. Before and after propensity score matching, we compared the incidence of postoperative AKI in patients who received intraoperative dexmedetomidine and those who did not. AKI was defined according to the Kidney Disease Improving Global Outcomes (creatinine alone values) criteria and calculated for postoperative Days 1, 2, and 3. Results Twenty per cent (n=1301) of the patients received dexmedetomidine. The mean [standard deviation] administered dose was 78 [49.4] mcg. Patients treated with dexmedetomidine were matched to those who did not receive the drug. Patients receiving dexmedetomidine had a longer anaesthesia duration than the non-dexmedetomidine group. The incidence of AKI was not significantly different between the groups (dexmedetomidine 8% vs no dexmedetomidine 7%; P=0.333). The 30 day rates of infection, cardiovascular complications, or reoperation attributable to bleeding were higher in patients treated with dexmedetomidine. The 30 day mortality rate was not statistically different between the groups. Conclusions The administration of dexmedetomidine during major non-cardiothoracic cancer surgery is not associated with a reduction in AKI within 72 h after surgery.
Collapse
Affiliation(s)
| | - Javier D. Lasala
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA
| | - Teresa Moon
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Shreyas Bhavsar
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Katherine Hagan
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Sarah Huepenbecker
- Department of Gynecology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Nicolas P. Carram
- Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA
- Department of Anaesthesia, Hospital General de Agudos ‘Teodoro Alvarez’, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
| | - Maria F. Ramirez
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA
| | - Kamal Maheswari
- Department of General Anesthesia and Outcomes Research, Anesthesia Institute, Cleveland Clinic, Cleveland, OH, USA
| | - Lei Feng
- Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Juan P. Cata
- Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA
| |
Collapse
|
6
|
Lewis VO, Kemp A, Roubaud MJ, Ajay D, Westney OL, Smith T, Dang AQ, Hagan K, Roland CL, Penny A, Adelman D. Multidisciplinary Approach to Hemipelvectomy for Pelvic Sarcomas. JBJS Rev 2022; 10:01874474-202205000-00007. [PMID: 37544929 DOI: 10.2106/jbjs.rvw.20.00233] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
» Pelvic sarcomas are a rare and diverse group of tumors in terms of size and histology.» Pelvic sarcomas present a treatment challenge to the orthopaedic oncologist.» The size and location of these tumors require a varied approach to resection and reconstruction, but the tumor's proximity to other internal structures within the pelvis (e.g., the bladder, the iliac vessels, and the bowel) makes extrication demanding.» The ideal treatment requires assembling a hemipelvectomy team that consists of an orthopaedic oncologist, a surgical oncologist, a urologist, a vascular surgeon, a gynecologic oncologist, a plastic and reconstructive surgeon, a dedicated anesthesia team, and a dedicated rehabilitation physical therapy team. Each member can use his or her expertise to address the individual aspects of the pelvic resection and achieve the optimal oncologic and functional outcome.
Collapse
Affiliation(s)
- Valerae O Lewis
- Department of Orthopaedic Oncology, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Alysia Kemp
- Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan
| | - Margaret J Roubaud
- Department of Plastic Surgery, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Divya Ajay
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - O Lenaine Westney
- Department of Urology, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Thomas Smith
- Department of Urology, MD Anderson Cancer Center, Houston, Texas
| | - Anh Quynh Dang
- Department of Anesthesiology & PeriOperative Medicine, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Katherine Hagan
- Department of Anesthesiology & PeriOperative Medicine, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Christina L Roland
- Department of Surgical Oncology, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - Alexander Penny
- Department of Orthopaedic Oncology, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| | - David Adelman
- Department of Plastic Surgery, Pelvic Sarcoma Center of Excellence, MD Anderson Cancer Center, Houston, Texas
| |
Collapse
|
7
|
Hagan K, Forman R, Mossialos E, Ndebele P, Hyder AA, Nasir K. COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy. Expert Rev Vaccines 2021; 21:37-45. [PMID: 34709969 DOI: 10.1080/14760584.2022.1999811] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Vaccination is the most effective strategy to mitigating COVID-19 and restoring societal function. As the pandemic evolves with no certainty of a herd immunity threshold, universal vaccination of at-risk populations is desirable. However, vaccine hesitancy threatens the return to normalcy, and healthcare workers (HCWs) must embrace their ambassadorial role of shoring up vaccine confidence. Unfortunately, voluntary vaccination has been suboptimal among HCWs in the United States, a priority group for whom immunization is essential for maintaining health system capacity and the safety of high-risk patients in their care. Consequently, some health systems have implemented mandates to improve compliance. AREAS COVERED This article discusses the ethical and practical considerations of mandatory COVID-19 vaccination policies for HCWs utilizing some components of the World Health Organization's framework and the unique context of a pandemic with evolving infection dynamics. EXPERT OPINION COVID-19 vaccine mandates for universal immunization of HCWs raise ethical and practical debates about their appropriateness, especially when the vaccines are pending full approval in most jurisdictions. Given the superiority of the vaccines to safety and testing protocols and their favorable safety profile, we encourage health systems to adopt vaccination mandates through participatory processes that address the concerns of stakeholders.
Collapse
Affiliation(s)
- K Hagan
- Division of Health Equity & Disparities Research, Center for Outcomes Research, Houston, TX, USA
| | - R Forman
- Department of Health Policy, London School of Economics and Political Sciences, UK
| | - Elias Mossialos
- Department of Health Policy, London School of Economics and Political Sciences, UK.,Center for Health Policy, Imperial College London, UK
| | - Paul Ndebele
- Department of Global Health, The George Washington University, Washington, DC, USA
| | - Adnan A Hyder
- Center on Commercial Determinants of Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA
| | - Khurram Nasir
- Division of Health Equity & Disparities Research, Center for Outcomes Research, Houston, TX, USA.,Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.,Center for Cardiovascular Computational & Precision Health (C3-PH), Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA
| |
Collapse
|
8
|
George D, Agarwal N, Ramaswamy K, Sandin R, Russell D, Hong A, Yang H, Gao W, Hagan K, Freedland S. 616P Real-world utilization of advanced therapies by metastatic site and age among patients with metastatic castration-sensitive prostate cancer (mCSPC): A Medicare database analysis. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 2020; 8:E115-E121. [PMID: 32010742 PMCID: PMC6976333 DOI: 10.1055/a-1012-1811] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Accepted: 06/26/2019] [Indexed: 12/11/2022] Open
Abstract
Background and study aims Endoscopic mucosal resection (EMR) is increasingly used for the treatment of large colonic polyps (≥ 20 mm). A drawback of EMR is local adenoma recurrence. Therefore, we studied the impact of argon plasma coagulation (APC) of the EMR edge on local adenoma recurrence. Patients and methods This was a retrospective study of patients with laterally spreading tumors (LST) ≥ 20 mm, who underwent EMR from January 2009 to August 2018 and follow-up endoscopic assessment. A cap-fitted endoscope was used to assess completeness of resection by systematically inspecting the EMR defect for any macroscopic disease. This was followed by forced APC of the resection edge followed by clip closure of the defect. Surveillance colonoscopy was performed at 6 months after resection to detect recurrence. Results Two hundred forty-six patients met the inclusion criteria. Most were female (53 %) and white (80 %), with a Median age of 64 years. Median polyp size was 35 mm (interquartile range, 30-45 mm). Most polyps were located in the right colon (77 %) and were removed by piecemeal EMR (70 %). Eleven patients (5 %) had residual tumor at the resection site. Conclusions We observed low adenoma recurrence after argon plasma coagulation of the EMR edge with a cap fitted colonoscope in patients with LST ≥ 20 mm of the colon, which requires further validation in a randomized controlled study.
Collapse
Affiliation(s)
- Gottumukkala S. Raju
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Phillip Lum
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Hamzah Abu-Sbeih
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - William A. Ross
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Selvi Thirumurthi
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Ethan Miller
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Patrick Lynch
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Jeffrey Lee
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Manoop S. Bhutani
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Mehnaz Shafi
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Brian Weston
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Asif Rashid
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Yinghong Wang
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - George J. Chang
- Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Richard Carlson
- Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Katherine Hagan
- Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Marta Davila
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - John Stroehlein
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| |
Collapse
|
10
|
Hagan K, Carlson R, Arnold B, Nguyen L, Lee J, Weston B, Syed T, Feng L, Hernandez M, Hagberg C. Is the Gastro™ LMA® a feasible alternative to a native airway for endoscopic retrograde cholangiopancreatography? Trends in Anaesthesia and Critical Care 2020. [DOI: 10.1016/j.tacc.2019.12.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
11
|
Knight MT, Newman MC, Benzinger MJ, Neufang KL, Agin JR, McAllister JS, Ramos M, Carter M, Duran B, Hagan K, Hansen R, Rudolph C, Quinley S, Updaw A, Neufang K, Brook L, Lucia L, Koeritzer B, Tomer J, Smith T, Brown D, Lobo C, Tobin P, O’Brien-Gammon L, Boleszcczuk P. Comparison of the Petrifilm Dry Rehydratable Film and Conventional Culture Methods for Enumeration of Yeasts and Molds in Foods: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/80.4.806] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A collaborative study was performed involving 18 laboratories and 6 food types to compare 3M Petrifilm yeast and mold count plates with the method described in the U.S. Food and Drug Administration’s Bacteriological Analytical Manual. Four species of mold and 2 species of yeast were used to inoculate the following foods: hot dogs, corn meal, ketchup, orange juice, yogurt, and cake mix. Each collaborator received 15 samples of each food type: 5 low-level inoculations, 5 high- level inoculations, and 5 uninoculated samples. There was no significant difference between the means of the 2 methods for any product or inoculation level. The Petrifilm yeast and mold count plate method for enumeration of yeasts and molds in foods has been adopted first action by AOAC INTERNATIONAL.
Collapse
Affiliation(s)
| | | | | | - Karen L Neufang
- Q Laboratories, Inc., 2014 Harrison Ave, Cincinnati, OH 45214
| | - James R Agin
- Q Laboratories, Inc., 2014 Harrison Ave, Cincinnati, OH 45214
| | - J Sue McAllister
- 3M Microbiology Products, 3M Center Bldg. 270-3N-04, St. Paul, MN 55144
| | - Mary Ramos
- 3M Microbiology Products, 3M Center Bldg. 270-3N-04, St. Paul, MN 55144
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps. Endosc Int Open 2019; 7:E361-E366. [PMID: 30834295 PMCID: PMC6395098 DOI: 10.1055/a-0746-3520] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Accepted: 08/09/2018] [Indexed: 12/26/2022] Open
Abstract
Background and study aims Endoscopic mucosal resection (EMR) is safe and cost-effective in management of patients with colon polyps. However, very little is known about the actions of the referring endoscopist following identification of these lesions at index colonoscopy, and the impact of those actions on the outcome of subsequent referral for EMR. The aim of this study was to identify practices at index colonoscopy that lead to failure of subsequent EMR. Patients and methods Two hundred and eighty-nine consecutive patients with biopsy-proven non-malignant colon polyps (> 20 mm) referred for EMR were analyzed to identify practices that could be improved from the time of identifying the lesion at index colonoscopy until completion of therapy. Results EMR was abandoned at colonoscopy at the EMR center in 71 of 289 patients (24.6 %). Reasons for abandoning EMR included diagnosis of invasive carcinoma (n = 9; 12.7 %), tethered lesions (n = 21; 29.6 %) from prior endoscopic interventions, and overly large (n = 22; 31 %) and inaccessible lesions (n = 17; 24 %) for complete and safe resection whose details were not recorded in the referring endoscopy report, or polyposis syndromes (n = 2; 2.8 %) that were not recognized. Conclusions In our practice, one in four EMR attempts were abandoned as a result of inadequate diagnosis or management by the referring endoscopist, which could be improved by education on optical diagnosis of polyps, comprehensive documentation of the procedure and avoidance of interventions that preclude resection.
Collapse
Affiliation(s)
- Gottumukkala Raju
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States,Corresponding author Gottumukkala Raju The University of Texas MD Anderson Cancer CenterGastroenterology, Hepatology and Nutrition1515 Holcombe BoulevardGI Division – Unit 1466Houston, TX 77030-4009United States+1-713-563-4408
| | - Phillip Lum
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - William Ross
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Selvi Thirumurthi
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Ethan Miller
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Patrick Lynch
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Jeffrey Lee
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Manoop S. Bhutani
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Mehnaz A. Shafi
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Brian Weston
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Boris Blechacz
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - George J Chang
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Katherine Hagan
- Department of Anesthesiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Asif Rashid
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - Marta Davila
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| | - John Stroehlein
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
| |
Collapse
|
13
|
Zeleznik OA, Poole EM, Lindstrom S, Kraft P, Van Hylckama Vlieg A, Lasky-Su JA, Harrington L, Hagan K, Kim J, Parry B, Giordano N, Kabrhel C. Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes. J Thromb Haemost 2018; 16:500-507. [PMID: 29285876 PMCID: PMC5826867 DOI: 10.1111/jth.13937] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Indexed: 02/01/2023]
Abstract
Essentials Risk-stratification often fails to predict clinical deterioration in pulmonary embolism (PE). First-ever high-throughput metabolomics analysis of risk-stratified PE patients. Changes in circulating metabolites reflect a compromised energy metabolism in PE. Metabolites play a key role in the pathophysiology and risk stratification of PE. SUMMARY Background Patients with acute pulmonary embolism (PE) exhibit wide variation in clinical presentation and outcomes. Our understanding of the pathophysiologic mechanisms differentiating low-risk and high-risk PE is limited, so current risk-stratification efforts often fail to predict clinical deterioration and are insufficient to guide management. Objectives To improve our understanding of the physiology differentiating low-risk from high-risk PE, we conducted the first-ever high-throughput metabolomics analysis (843 named metabolites) comparing PE patients across risk strata within a nested case-control study. Patients/methods We enrolled 92 patients diagnosed with acute PE and collected plasma within 24 h of PE diagnosis. We used linear regression and pathway analysis to identify metabolites and pathways associated with PE risk-strata. Results When we compared 46 low-risk with 46 intermediate/high-risk PEs, 50 metabolites were significantly different after multiple testing correction. These metabolites were enriched in the following pathways: tricarboxylic acid (TCA) cycle, fatty acid metabolism (acyl carnitine) and purine metabolism, (hypo)xanthine/inosine containing. Additionally, energy, nucleotide and amino acid pathways were downregulated in intermediate/high-risk PE patients. When we compared 28 intermediate-risk with 18 high-risk PE patients, 41 metabolites differed at a nominal P-value level. These metabolites were enriched in fatty acid metabolism (acyl cholines), and hemoglobin and porphyrin metabolism. Conclusion Our results suggest that high-throughput metabolomics can provide insight into the pathophysiology of PE. Specifically, changes in circulating metabolites reflect compromised energy metabolism in intermediate/high-risk PE patients. These findings demonstrate the important role metabolites play in the pathophysiology of PE and highlight metabolomics as a potential tool for risk stratification of PE.
Collapse
Affiliation(s)
- O. A. Zeleznik
- Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, United States
- Harvard Medical School, Department of Medicine, Boston, United States
| | - E. M. Poole
- Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, United States
- Harvard Medical School, Department of Medicine, Boston, United States
| | - S. Lindstrom
- University of Washington, Department of Epidemiology, Seattle, United States
- Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, United States
| | - P. Kraft
- Harvard T.H. Chan School of Public Health, Epidemiology, Boston, United States
| | | | - J. A. Lasky-Su
- Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, United States
| | - L.B. Harrington
- Harvard T.H. Chan School of Public Health, Nutrition, Boston, United States
| | - K. Hagan
- Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, United States
- Harvard Medical School, Department of Medicine, Boston, United States
| | - J. Kim
- Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, United States
- Harvard T.H. Chan School of Public Health, Epidemiology, Boston, United States
| | - B.A. Parry
- Massachusetts General Hospital, Center for Vascular Emergencies, Department of Emergency Medicine, Boston, United States
| | - N. Giordano
- Massachusetts General Hospital, Center for Vascular Emergencies, Department of Emergency Medicine, Boston, United States
| | - C. Kabrhel
- Massachusetts General Hospital, Center for Vascular Emergencies, Department of Emergency Medicine, Boston, United States
- Harvard Medical School, Department of Emergency Medicine, Boston, United States
| |
Collapse
|
14
|
Banerjee U, Hagan K, Bhavsar S, Grasu R, Dang A, McCutcheon IE, Suarez M, Gottumukkala V, Cata JP. Association between intravenous acetaminophen and reduction in intraoperative opioid consumption during transsphenoidal surgery for pituitary tumors. J Anaesthesiol Clin Pharmacol 2018; 34:465-471. [PMID: 30787509 PMCID: PMC6360881 DOI: 10.4103/joacp.joacp_276_17] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Background and Aims Pain during and after transsphenoidal surgeries originates from stimulation of branches of the trigeminal cranial nerve that supply the inner aspect of the nose cavity and dura mater. Thereby, patients undergoing transsphenoidal surgery may require moderate-to-large amounts of analgesics including opioids. Intravenous acetaminophen provides analgesia and reduces opioid consumption for a wide variety of surgeries. We hypothesized that the use of intravenous acetaminophen is associated with a reduction in intraoperative opioid consumption and provides significant analgesia during and after transsphenoidal surgery. Material and Methods This retrospective study included 413 patients who underwent transsphenoidal surgery for pituitary adenomas. The primary outcome of this study was intraoperative opioid consumption. Secondary outcomes included pain intensity, Richmond Agitation Sedation Scale scores, and nausea and vomiting upon arrival to postoperative anesthesia care unit. Patients were divided into two groups based on the intraoperative acetaminophen use. A prospensity score matching analysis was used to balance for important variables between the two groups of treatment. Regression models were fitted after matching the covariates. A P < 0.05 was considered statistically significant. Results After matching, 126 patients were included in each group of treatment. Patients in the acetaminophen group required significantly less amount (a decrease by 14.9%) of opioids during surgery than those in the non-acetaminophen group. Postoperative pain, postoperative nausea and vomiting, and sedation scores were not significantly different between patients who received intravenous acetaminophen and those who did not. Conclusion Intravenous acetaminophen is associated with a reduction in intraoperative opioids during transsphenoidal pituitary surgery.
Collapse
Affiliation(s)
- Upasana Banerjee
- Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.,School of Biomedical Informatics, The University of Texas Health Science Center, Houston, Texas, USA
| | - Katherine Hagan
- Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Shreyas Bhavsar
- Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Roxana Grasu
- Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Anh Dang
- Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Ian E McCutcheon
- Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.,Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Miguel Suarez
- Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.,Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Vijaya Gottumukkala
- Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.,Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Juan P Cata
- Anesthesiology and Surgical Oncology Research Group, Houston, Texas, USA.,Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
15
|
Farzam P, Buckley EM, Lin PY, Hagan K, Grant PE, Inder TE, Carp SA, Franceschini MA. Shedding light on the neonatal brain: probing cerebral hemodynamics by diffuse optical spectroscopic methods. Sci Rep 2017; 7:15786. [PMID: 29150648 PMCID: PMC5693925 DOI: 10.1038/s41598-017-15995-1] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2017] [Accepted: 11/03/2017] [Indexed: 11/24/2022] Open
Abstract
Investigating the cerebral physiology of healthy term newborns' brains is important for better understanding perinatal brain injuries, of which the most common etiologies are hypoxia and ischemia. Hence, cerebral blood flow and cerebral oxygenation are important biomarkers of brain health. In this study, we employed a hybrid diffuse optical system consisting of diffuse correlation spectroscopy (DCS) and frequency-domain near infrared spectroscopy (FDNIRS) to measure hemoglobin concentration, oxygen saturation, and indices of cerebral blood flow and metabolism. We measured 30 term infants to assess the optical and physiological characteristics of the healthy neonatal brain in the frontal, temporal, and parietal lobes. We observed higher metabolism in the right hemisphere compared to the left and a positive correlation between gestational age and the level of cerebral hemoglobin concentration, blood volume, and oxygen saturation. Moreover, we observed higher cerebral blood flow and lower oxygen saturation in females compared to males. The delayed maturation in males and the sexual dimorphism in cerebral hemodynamics may explain why males are more vulnerable to perinatal brain injuries than females.
Collapse
Affiliation(s)
- Parisa Farzam
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA.
| | - Erin M Buckley
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA
- Georgia Institute of Technology, Atlanta, GA, 30322, USA
| | - Pei-Yi Lin
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA
| | - Katherine Hagan
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA
| | - P Ellen Grant
- Fetal-Neonatal Neuroimaging and Developmental Science Center, Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Terrie Eleanor Inder
- Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Stefan A Carp
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA
| | - Maria Angela Franceschini
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA
| |
Collapse
|
16
|
Roberts SB, Franceschini MA, Krauss A, Lin PY, Braima de Sa A, Có R, Taylor S, Brown C, Chen O, Johnson EJ, Pruzensky W, Schlossman N, Balé C, Wu KC(T, Hagan K, Saltzman E, Muentener P. A Pilot Randomized Controlled Trial of a New Supplementary Food Designed to Enhance Cognitive Performance during Prevention and Treatment of Malnutrition in Childhood. Curr Dev Nutr 2017; 1:e000885. [PMID: 29658962 PMCID: PMC5898396 DOI: 10.3945/cdn.117.000885] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 06/11/2017] [Accepted: 10/12/2017] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Cognitive impairment associated with childhood malnutrition and stunting is generally considered irreversible. OBJECTIVE The aim was to test a new nutritional supplement for the prevention and treatment of moderate-acute malnutrition (MAM) focused on enhancing cognitive performance. METHODS An 11-wk, village-randomized, controlled pilot trial was conducted in 78 children aged 1-3 or 5-7 y living in villages in Guinea-Bissau. The supplement contained 291 kcal/d for young children and 350 kcal/d for older children and included 5 nutrients and 2 flavan-3-ol-rich ingredients not present in current food-based recommendations for MAM. Local bakers prepared the supplement from a combination of locally sourced items and an imported mix of ingredients, and it was administered by community health workers 5 d/wk. The primary outcome was executive function abilities at 11 wk. Secondary outcomes included additional cognitive measures and changes in z scores for weight (weight-for-age) and height (height-for-age) and hemoglobin concentrations at 11 wk. An index of cerebral blood flow (CBF) was also measured at 11 wk to explore the use of this measurement as a biological index of cognitive impairment. RESULTS There were no significant differences in any outcome between groups at baseline. There was a beneficial effect of random assignment to the supplement group on working memory at 11 wk in children aged 1-3 y (P < 0.05). This difference contrasted with no effect in older children and was not associated with faster growth rate. In addition, CBF correlated with task-switching performance (P < 0.05). CONCLUSIONS These preliminary data suggest that cognitive impairment can be monitored with measurement of CBF. In addition, the findings provide preliminary data that suggest that it may be possible to improve poor cognitive performance in young children through changes in the nutritional formulation of supplementary foods used to prevent and treat MAM. Powered studies of the new supplement formulation are needed. This trial was registered at clinicaltrials.gov as NCT03017209.
Collapse
Affiliation(s)
- Susan B Roberts
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
| | | | - Amy Krauss
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
| | - Pei-Yi Lin
- Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA
| | - Augusto Braima de Sa
- International Partnership for Human Development, Leesburg, VA
- International Partnership for Human Development, Bissau, Guinea-Bissau
| | - Raimundo Có
- International Partnership for Human Development, Leesburg, VA
- International Partnership for Human Development, Bissau, Guinea-Bissau
| | - Salima Taylor
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
| | - Carrie Brown
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
| | - Oliver Chen
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
| | - Elizabeth J Johnson
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
| | - William Pruzensky
- International Partnership for Human Development, Leesburg, VA
- International Partnership for Human Development, Bissau, Guinea-Bissau
| | | | - Carlito Balé
- International Partnership for Human Development, Leesburg, VA
- International Partnership for Human Development, Bissau, Guinea-Bissau
| | - Kuan-Cheng (Tony) Wu
- Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA
| | - Katherine Hagan
- Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA
| | - Edward Saltzman
- USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
| | | |
Collapse
|
17
|
Lin PY, Cheng FY, Hagan K, Sheldon Y, Grant EP, Franceschini MA. Abstract TP400: Evoked Functional Cerebral Hemodynamic and Metabolic Responses in Premature Infants with and without Germinal Matrix Hemorrhage. Stroke 2017. [DOI: 10.1161/str.48.suppl_1.tp400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We have created an innovative new method which uses frequency domain near-infrared spectroscopy (FDNIRS) in
combination with diffuse correlation spectroscopy (DCS) to quantitatively measure cerebral blood flow (CBF) and oxygen
metabolism (CMRO
2
) right at the infant’s bedside. We have previously found CBF and CMRO
2
are more sensitive indicators
of cerebral pathophysiology than hemoglobin saturation (SO
2
). Using FDNIRS-DCS, we had found extremely premature
infants with germinal matrix hemorrhage (GMH) have lower cerebral blood flow (CBF) and oxygen metabolism
(CMRO
2
)
than gestational age-matched controls. For this study, we investigate whether GMH, along with age and
hematocrit levels, affect evoked hemodynamic responses. The study protocol was reviewed and approved by the
Institutional Review Board for Partners Healthcare. We enrolled eleven premature infants in the neonatal intensive care
unit at Brigham and Women’s Hospital. Three of them had Grade I GMH diagnosed by head ultrasound on the first three
days of life. We integrated continuous wave NIRS (CWNIRS) with DCS to measure dynamic changes of cerebral hemoglobin
concentrations (HbO) and CBF in response to somatosensory stimuli. For each measurement, we measured differential
path length factors and baseline cerebral hemoglobin concentrations with FDNIRS to quantify relative hemodynamic and
metabolic changes (rHbO, rCBF and rCMRO
2
) in response to tactile stimulation. We observed a faster response time to
reach peak value in preterm infants with increasing postmenstrual age (PMA), demonstrating the response matures with
age to become more adult-like (r=-0.513, p=0.007). In addition, infants measured at older PMA tend to have responses
with a larger undershoot in HbO. However, the HbO undershoot did not translate into an undershoot in CMRO
2
. The HbO
undershoot may therefore be a consequence of low hematocrit during the first two months of life which results in
insufficient oxygen supply and leads to abnormally large oxygen extraction from the blood. We found the activation
pattern of Grade I GMH infants did not differ from premature infants without hemorrhage. The study is ongoing and shows
our method is suitable to measure cerebral maturation in neonates with hemorrhage.
Collapse
Affiliation(s)
- Pei-Yi Lin
- Radiology, Massachusetts General Hosp, Charlestown, MA
| | - Fang-Yu Cheng
- Radiology, Massachusetts General Hosp, Charlestown, MA
| | | | | | | | | |
Collapse
|
18
|
Dehaes M, Cheng HH, Buckley EM, Lin PY, Ferradal S, Williams K, Vyas R, Hagan K, Wigmore D, McDavitt E, Soul JS, Franceschini MA, Newburger JW, Ellen Grant P. Perioperative cerebral hemodynamics and oxygen metabolism in neonates with single-ventricle physiology. Biomed Opt Express 2015; 6:4749-67. [PMID: 26713191 PMCID: PMC4679251 DOI: 10.1364/boe.6.004749] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2015] [Revised: 11/01/2015] [Accepted: 11/03/2015] [Indexed: 05/03/2023]
Abstract
Congenital heart disease (CHD) patients are at risk for neurodevelopmental delay. The etiology of these delays is unclear, but abnormal prenatal cerebral maturation and postoperative hemodynamic instability likely play a role. A better understanding of these factors is needed to improve neurodevelopmental outcome. In this study, we used bedside frequency-domain near infrared spectroscopy (FDNIRS) and diffuse correlation spectroscopy (DCS) to assess cerebral hemodynamics and oxygen metabolism in neonates with single-ventricle (SV) CHD undergoing surgery and compared them to controls. Our goals were 1) to compare cerebral hemodynamics between unanesthetized SV and healthy neonates, and 2) to determine if FDNIRS-DCS could detect alterations in cerebral hemodynamics beyond cerebral hemoglobin oxygen saturation (SO 2). Eleven SV neonates were recruited and compared to 13 controls. Preoperatively, SV patients showed decreased cerebral blood flow (CBFi ), cerebral oxygen metabolism (CMRO 2i ) and SO 2; and increased oxygen extraction fraction (OEF) compared to controls. Compared to preoperative values, unstable postoperative SV patients had decreased CMRO 2i and CBFi , which returned to baseline when stable. However, SO 2 showed no difference between unstable and stable states. Preoperative SV neonates are flow-limited and show signs of impaired cerebral development compared to controls. FDNIRS-DCS shows potential to improve assessment of cerebral development and postoperative hemodynamics compared to SO 2 alone.
Collapse
Affiliation(s)
- Mathieu Dehaes
- Fetal Neonatal Neuroimaging & Developmental Science Center, Division of Newborn Medicine, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
- Mathieu Dehaes is currently at University of Montréal and Centre Hospitalier Universitaire Sainte-Justine, Montréal (QC), H3T 1C5,
Canada
- Mathieu Dehaes and Henry H. Cheng contributed equally to this work
| | - Henry H. Cheng
- Department of Cardiology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
- Mathieu Dehaes and Henry H. Cheng contributed equally to this work
| | - Erin M. Buckley
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129,
USA
- Erin M. Buckley is currently at Georgia Institute of Technology, Atlanta, GA 30322,
USA
| | - Pei-Yi Lin
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129,
USA
| | - Silvina Ferradal
- Fetal Neonatal Neuroimaging & Developmental Science Center, Division of Newborn Medicine, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Kathryn Williams
- Department of Cardiology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Rutvi Vyas
- Fetal Neonatal Neuroimaging & Developmental Science Center, Division of Newborn Medicine, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Katherine Hagan
- Fetal Neonatal Neuroimaging & Developmental Science Center, Division of Newborn Medicine, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Daniel Wigmore
- Department of Cardiology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Erica McDavitt
- Department of Cardiology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Janet S. Soul
- Department of Neurology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - Maria Angela Franceschini
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129,
USA
| | - Jane W. Newburger
- Department of Cardiology, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| | - P. Ellen Grant
- Fetal Neonatal Neuroimaging & Developmental Science Center, Division of Newborn Medicine, Boston Children’s Hospital & Harvard Medical School, Boston, MA 02115,
USA
| |
Collapse
|
19
|
Lin PY, Roche-Labarbe N, Dehaes M, Carp S, Fenoglio A, Barbieri B, Hagan K, Grant PE, Franceschini MA. Non-invasive optical measurement of cerebral metabolism and hemodynamics in infants. J Vis Exp 2013:e4379. [PMID: 23524854 PMCID: PMC3639513 DOI: 10.3791/4379] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Perinatal brain injury remains a significant cause of infant mortality and morbidity, but there is not yet an effective bedside tool that can accurately screen for brain injury, monitor injury evolution, or assess response to therapy. The energy used by neurons is derived largely from tissue oxidative metabolism, and neural hyperactivity and cell death are reflected by corresponding changes in cerebral oxygen metabolism (CMRO2). Thus, measures of CMRO2 are reflective of neuronal viability and provide critical diagnostic information, making CMRO2 an ideal target for bedside measurement of brain health. Brain-imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) yield measures of cerebral glucose and oxygen metabolism, but these techniques require the administration of radionucleotides, so they are used in only the most acute cases. Continuous-wave near-infrared spectroscopy (CWNIRS) provides non-invasive and non-ionizing radiation measures of hemoglobin oxygen saturation (SO2) as a surrogate for cerebral oxygen consumption. However, SO2 is less than ideal as a surrogate for cerebral oxygen metabolism as it is influenced by both oxygen delivery and consumption. Furthermore, measurements of SO2 are not sensitive enough to detect brain injury hours after the insult 1,2, because oxygen consumption and delivery reach equilibrium after acute transients3. We investigated the possibility of using more sophisticated NIRS optical methods to quantify cerebral oxygen metabolism at the bedside in healthy and brain-injured newborns. More specifically, we combined the frequency-domain NIRS (FDNIRS) measure of SO2 with the diffuse correlation spectroscopy (DCS) measure of blood flow index (CBFi) to yield an index of CMRO2 (CMRO2i) 4,5. With the combined FDNIRS/DCS system we are able to quantify cerebral metabolism and hemodynamics. This represents an improvement over CWNIRS for detecting brain health, brain development, and response to therapy in neonates. Moreover, this method adheres to all neonatal intensive care unit (NICU) policies on infection control and institutional policies on laser safety. Future work will seek to integrate the two instruments to reduce acquisition time at the bedside and to implement real-time feedback on data quality to reduce the rate of data rejection.
Collapse
Affiliation(s)
- Pei-Yi Lin
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Morris R, Woo Y, Hagan K, Chambers S, Jessup M, Acker M. 712: Transplant in the Elderly vs. Destination Therapy: Beginning of a Paradigm Shift? J Heart Lung Transplant 2009. [DOI: 10.1016/j.healun.2008.11.719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
21
|
Moore MJ, Hamm J, Dancey J, Eisenberg PD, Dagenais M, Fields A, Hagan K, Greenberg B, Colwell B, Zee B, Tu D, Ottaway J, Humphrey R, Seymour L. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003; 21:3296-302. [PMID: 12947065 DOI: 10.1200/jco.2003.02.098] [Citation(s) in RCA: 268] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
PURPOSE To compare the selective matrix metalloproteinase inhibitor BAY 12-9566 with the nucleoside analog gemcitabine in the treatment of advanced pancreatic cancer. METHODS Patients with advanced pancreatic adenocarcinoma who had not previously received chemotherapy were randomly assigned to receive BAY 12-9566 800 mg orally bid continuously or gemcitabine 1,000 mg/m2 administered intravenously on days 1, 8, 15, 22, 29, 36, and 43 for the first 8 weeks, and then days 1, 8, and 15 of each subsequent 28-day cycle. The primary end point was overall survival; secondary end points were progression-free survival, tumor response, quality of life, and clinical benefit. The planned sample size of the study was 350 patients. Two formal interim analyses were planned. RESULTS The study was closed to accrual after the second interim analysis on the basis of the recommendation of the National Cancer Institute of Canada Clinical Trials Group Data Safety Monitoring Committee. There were 277 patients enrolled onto the study, 138 in the BAY 12-9566 arm and 139 in the gemcitabine arm. The rates of serious toxicity were low in both arms. The median survival for the BAY 12-9566 arm and the gemcitabine arm was 3.74 months and 6.59 months, respectively (P <.001; stratified log-rank test). The median progression-free survival for the BAY 12-9566 and gemcitabine arms was 1.68 and 3.5 months, respectively (P <.001). Quality-of-life analysis also favored gemcitabine. CONCLUSION Gemcitabine is significantly superior to BAY 12-9566 in advanced pancreatic cancer.
Collapse
Affiliation(s)
- M J Moore
- Department of Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the K(L) charge asymmetry. Phys Rev Lett 2002; 88:181601. [PMID: 12005674 DOI: 10.1103/physrevlett.88.181601] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2001] [Indexed: 05/23/2023]
Abstract
We present a measurement of the charge asymmetry delta(L) in the mode K(L)-->pi(+/-)e(-/+)nu based on 298 x 10(6) analyzed decays. We measure a value of delta(L) = [3322+/-58(stat)+/-47(syst)]x10(-6), in good agreement with previous measurements and 2.4 times more precise than the current best published result. The result is used to place more stringent limits on CPT and DeltaS = DeltaQ violation in the neutral kaon system.
Collapse
|
23
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. First measurement of form factors of the decay Xi(0) --> Sigma(+)e(-)nu macro(e). Phys Rev Lett 2001; 87:132001. [PMID: 11580577 DOI: 10.1103/physrevlett.87.132001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2001] [Indexed: 05/23/2023]
Abstract
We present the first measurement of the form factor ratios g(1)/f(1) (direct axial vector to vector), g(2)/f(1) (second class current), and f(2)/f(1) (weak magnetism) for the decay Xi(0)-->Sigma(+)e(-)nu macro(e) using the KTeV (E799) beam line and detector at Fermilab. From the Sigma(+) polarization measured with the decay Sigma(+)-->p pi(0) and the e(-)-nu; correlation, we measure g(1)/f(1) to be 1.32+/-(0.21)(0.17)(stat)+/-0.05(syst), assuming the SU(3)(f) (flavor) values for g(2)/f(1) and f(2)/f(1). Our results are all consistent with exact SU(3)(f) symmetry.
Collapse
|
24
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Qi XR, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Branching ratio measurement of the decay K(L) --> e(+)e(-)mu(+)mu(-). Phys Rev Lett 2001; 87:111802. [PMID: 11531512 DOI: 10.1103/physrevlett.87.111802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2001] [Indexed: 05/23/2023]
Abstract
We have collected a 43 event sample of the decay K(L)-->e(+)e(-)mu(+)mu(-) with negligible backgrounds and measured its branching ratio to be (2.62+/-0.40+/-0.17)x10(-9). We see no evidence for CP violation in this decay. In addition, we set the 90% confidence upper limit on the combined branching ratios for the lepton flavor violating decays K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+) at B(K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+))< or =1.23x10(-10), assuming a uniform phase space distribution.
Collapse
|
25
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the branching ratio and form factor of K(L)-->mu(+)mu(-)gamma. Phys Rev Lett 2001; 87:071801. [PMID: 11497879 DOI: 10.1103/physrevlett.87.071801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2001] [Indexed: 05/23/2023]
Abstract
We report on the analysis of the rare decay K(L)-->mu(+)mu(-)gamma the 1997 data from the KTeV experiment at Fermilab. A total of 9327 candidate events are observed with 2.4% background, representing a factor of 40 increase in statistics over the current world sample. We find that B(K(L)-->mu(+)mu(-)gamma) = (3.62 +/- 0.04(stat) +/- 0.08(syst)) x 10(-7). The form factor parameter alpha(K*) is measured to be alpha(K*) = -0.160(+0.026)(-0.028). In addition, we make the first measurement of the parameter alpha from the D'Ambrosio-Isidori-Portolés form factor, finding alpha = -1.54 +/- 0.10. In that model, this alpha measurement limits the Cabibbo-Kobayashi-Maskawa parameter rho>-0.2.
Collapse
|
26
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurements of the rare decay K(L) --> e(+)e(-)e(+)e(-). Phys Rev Lett 2001; 86:5425-5429. [PMID: 11415267 DOI: 10.1103/physrevlett.86.5425] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2001] [Indexed: 05/23/2023]
Abstract
We observe 441 K(L)-->e(+)e(-)e(+)e(-) candidate events with a background of 4.2 events and measure B(K(L)-->e(+)e(-)e(+)e(-)) = [3.72+/-0.18(stat)+/-0.23(syst)]x10(-8) in the KTeV/E799II experiment at Fermilab. Using the distribution of the angle between the planes of the e(+)e(-) pairs, we measure the CP parameters beta(CP) = -0.23+/-0.09(stat)+/-0.02(syst) and gamma(CP) = -0.09+/-0.09(stat)+/-0.02(syst). We also present the first detailed study of the e(+)e(-) invariant mass spectrum in this decay mode.
Collapse
|
27
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the branching ratio and asymmetry of the decay Xi degrees -->Sigma degrees gamma. Phys Rev Lett 2001; 86:3239-3243. [PMID: 11327940 DOI: 10.1103/physrevlett.86.3239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2000] [Indexed: 05/23/2023]
Abstract
We have studied the rare weak radiative hyperon decay Xi degrees -->Sigma degrees gamma in the KTeV experiment at Fermilab. We have identified 4045 signal events over a background of 804 events. The dominant Xi degrees -->Lambdapi degrees decay, which was used for normalization, is the only important background source. An analysis of the acceptance of both modes yields a branching ratio of B(Xi degrees -->Sigma degrees gamma)/B(Xi degrees -->Lambdapi degrees ) = (3.34+/-0.05+/-0.09)x10(-3). By analyzing the final state decay distributions, we have also determined that the Sigma degrees emission asymmetry parameter for this decay is alpha(XiSigma) = -0.63+/-0.09.
Collapse
|
28
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Study of the K(0)(L) --> pi(+)pi(-)gamma Direct Emission Vertex. Phys Rev Lett 2001; 86:761-764. [PMID: 11177934 DOI: 10.1103/physrevlett.86.761] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2000] [Indexed: 05/23/2023]
Abstract
We have performed studies of the K(0)(L)-->pi(+)pi(-)gamma direct emission ( DE) and inner Bremsstrahlung ( IB) vertices, based on data collected by KTeV during the 1996 Fermilab fixed target run. We find a(1)/a(2) = -0.737+/-0.034 GeV2 for the DE form-factor parameter in the rho-propagator parametrization, and report on fits of the form factor to linear and quadratic functions as well. We concurrently measure gamma(K(0)(L)-->pi(+)pi(-)gamma,E(*)(gamma)>20 MeV)/gamma(K(0)(L)-->pi(+)pi(-)) = (20.8+/-0.3)x10(-3), and a K(0)(L)-->pi(+)pi(-)gamma DE/(DE+IB) branching ratio of 0.683+/-0.011.
Collapse
|
29
|
Alavi-Harati A, Albuquerque IF, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Fordyce PM, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jennings J, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, McManus AP, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qiao C, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Swanson RA, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Search for the decay KL --> pi(0)e+e-. Phys Rev Lett 2001; 86:397-401. [PMID: 11177840 DOI: 10.1103/physrevlett.86.397] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2000] [Indexed: 05/23/2023]
Abstract
We report on a search for the decay KL-->pi(0)e+e- carried out by the KTeV/E799 experiment at Fermilab. This decay is expected to have a significant CP violating contribution and the measurement of its branching ratio could support the Cabibbo-Kobayashi-Maskawa mechanism for CP violation or could point to new physics. Two events were observed in the 1997 data with an expected background of 1.06+/-0.41 events, and we set an upper limit B(KL-->pi(0)e+e-)<5.1 x 10(-10) at the 90% confidence level.
Collapse
|
30
|
Alavi-Harati A, Albuquerque IF, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hanagaki K, Hazumi M, Hidaka S, Hsiung YB, Jejer V, Jennings J, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, McManus AP, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O’Dell V, Pang M, Pordes R, Prasad V, Qiao C, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Swanson RA, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Evidence for the decayKL→μ+μ−γγ. Int J Clin Exp Med 2000. [DOI: 10.1103/physrevd.62.112001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
31
|
Abstract
Decapping is a rate-limiting step in the decay of many yeast mRNAs; the activity of the decapping enzyme therefore plays a significant role in determining RNA stability. Using an in vitro decapping assay, we have identified a factor, Vps16p, that regulates the activity of the yeast decapping enzyme, Dcp1p. Mutations in the VPS16 gene result in a reduction of decapping activity in vitro and in the stabilization of both wild-type and nonsense-codon-containing mRNAs in vivo. The mrt1-3 allele, previously shown to affect the turnover of wild-type mRNAs, results in a similar in vitro phenotype. Extracts from both vps16 and mrt1 mutant strains inhibit the activity of purified Flag-Dcp1p. We have identified a 70-kDa protein which copurifies with Flag-Dcp1p as the abundant Hsp70 family member Ssa1p/2p. Intriguingly, the interaction with Ssa1p/2p is enhanced in strains with mutations in vps16 or mrt1. We propose that Hsp70s may be involved in the regulation of mRNA decapping.
Collapse
Affiliation(s)
- S Zhang
- Department of Molecular Genetics, Robert Wood Johnson Medical School, New Jersey, USA
| | | | | | | |
Collapse
|
32
|
Rumsey WL, Abbott B, Bertelsen D, Mallamaci M, Hagan K, Nelson D, Erecinska M. Adaptation to hypoxia alters energy metabolism in rat heart. Am J Physiol 1999; 276:H71-80. [PMID: 9887019 DOI: 10.1152/ajpheart.1999.276.1.h71] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The present study characterized metabolic changes in the heart associated with long-term exposure to hypoxia, a potent stimulus for pulmonary hypertension and right ventricular hypertrophy. When anesthetized rats adapted to chronic hypoxia spontaneously respired room air, their mean right intraventricular peak systolic pressure (RVSP) was twice that in normal control animals with the same arterial PO2. RVSP was linearly related to right ventricular mass (r = 0.78). Oxidative capacity (O2 consumption) of homogenates of right and left ventricles from both groups of rats was measured with one of the following substrates: pyruvate, glutamate, acetate, and palmitoyl-L-carnitine. Oxidation of all substrates was significantly greater in the left than in the right ventricle in normal rats but not in hypoxia-adapted animals, where it was the same, within the experimental error. O2 consumption by the left ventricle was greater in control than in experimental rats, but right ventricular O2 consumption was similar in the two groups. Maximal reaction velocity of cytochrome-c oxidase was about the same in the two ventricles, and there were no significant differences between control and hypoxia-adapted animals. HPLC analyses showed significantly higher aspartate levels and aspartate-to glutamate concentration ratios in both ventricles of hypoxic rats than in corresponding tissues from controls, indicative of a decreased flux through the malate-aspartate shuttle under conditions of O2 limitation. Myocardial glutamine levels were lower in hypoxic rats, and glutamine-to-glutamate concentration ratios decreased, although primarily in the pressure-overloaded right ventricle. These findings indicate that normal energy metabolism in the left ventricle differs from that in the right and that the differences, particularly those of amino acid metabolism, are markedly influenced by chronic exposure to hypoxia.
Collapse
Affiliation(s)
- W L Rumsey
- Zeneca Pharmaceuticals, Wilmington, Delaware 19850, USA
| | | | | | | | | | | | | |
Collapse
|
33
|
Seal DV, Wright P, Ficker L, Hagan K, Troski M, Menday P. Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea. Br J Ophthalmol 1995; 79:42-5. [PMID: 7880791 PMCID: PMC505018 DOI: 10.1136/bjo.79.1.42] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
A prospective, randomised, double blind, partial crossover, placebo controlled trial has been conducted to compare the performance of topical fusidic acid gel (Fucithalmic) and oral oxytetracycline as treatment for symptomatic chronic blepharitis. Treatment success was judged both by a reduction in symptoms and clinical examination before and after therapy. Seventy five per cent of patients with blepharitis and associated rosacea were symptomatically improved by fusidic acid gel and 50% by oxytetracycline, but fewer (35%) appeared to benefit from the combination. Patients with chronic blepharitis of other aetiologies did not respond to fusidic acid gel but 25% did benefit from oxytetracycline and 30% from the combination. Our results demonstrate the need to investigate patients with blepharitis for concomitant rosacea as they respond well to targeted therapy.
Collapse
Affiliation(s)
- D V Seal
- Tennent Institute of Ophthalmology, Western Infirmary, Glasgow
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
Placement of enteral feeding tubes is an important part of a surgeon's skill base. Surgical insertion of feeding tubes has been performed safely for many years with very few modifications. With the recent surge in interest and applicability of other laparoscopic procedures, it is well within the skills of the average laparoscopic surgeon to insert feeding tubes. We describe herein a simple technique for the insertion of the Moss feeding tube. The procedure described has a minimum of invasion, along with simplicity, safety, and accuracy.
Collapse
Affiliation(s)
- M H Albrink
- Department of Surgery, University of South Florida, Tampa
| | | | | |
Collapse
|
35
|
Abstract
Laser Doppler flowmetry was used intraoperatively to differentiate viable from nonviable bone during the debridement of 12 cases of chronic osteomyelitis and three cases of acute bone infection following trauma. Six weeks of i.v. antibiotic therapy were directed against two cases of gram-positive and 13 cases of gram-negative bone infection. In cases of chronic infection, free muscle flaps were added for soft tissue coverage in five cases and rotational muscle flaps in four cases. At follow-up observation, of 1 to 3 years, no recurrences were seen. Laser Doppler flowmetry is an easy-to-use adjunct to the surgical debridement of bone infection.
Collapse
Affiliation(s)
- M F Swiontkowski
- Department of Orthopaedics and Rehabilitation, Vanderbilt University, Nashville, Tennessee
| | | | | |
Collapse
|
36
|
|
37
|
Hagan K. Comments from the readers: dosage of actinomycin. South Med J 1972; 65:1511. [PMID: 4641096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
38
|
Goto H, Burger D, Hagan K. Pseudorabies virus in mice: failure to demonstrate maternal antibodies. Am J Vet Res 1970; 31:951-3. [PMID: 5442457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|